VedolizumabAcute tubulointerstitial nephritis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1969卷 / 1期

关键词：

D O I：

10.1007/s40278-023-44836-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：370 / 370

相关论文

共 50 条

[41] Clindamycin/flucloxacillinAcute tubulointerstitial nephritis: case report
Reactions Weekly, 2023, 1963 (1) : 167 - 167
[42] Ipilimumab/nivolumabAcute tubulointerstitial nephritis: case report
Reactions Weekly, 2024, 2036 (1) : 229 - 229
[43] ImmunoglobulinsAcute tubulointerstitial nephritis in a child: case report
Reactions Weekly, 2000, 796 (1) : 8 - 8
[44] Ipilimumab/NivolumabAcute tubulointerstitial nephritis: case report
Reactions Weekly, 2023, 1985 (1) : 270 - 270
[45] AdalimumabUnmasking of tubulointerstitial nephritis and uveitis: case report
Reactions Weekly, 2021, 1838 (1) : 20 - 20
[46] MesalazineAcute tubulointerstitial nephritis and glomerulosclerosis: case report
Reactions Weekly, 2023, 1957 (1) : 356 - 356
[47] Nivolumab/rabeprazoleAcute tubulointerstitial nephritis: case report
Reactions Weekly, 2018, 1730 (1) : 236 - 236
[48] SitagliptinAcute tubulointerstitial nephritis (ATIN): case report
Reactions Weekly, 2016, 1616 (1) : 142 - 142
[49] MesalazineAcute and chronic tubulointerstitial nephritis: case report
Reactions Weekly, 2023, 1966 (1) : 205 - 205
[50] VedolizumabAcute pancreatitis: case report
Reactions Weekly, 2020, 1805 (1) : 302 - 302

← 1 2 3 4 5 →